Scleroderma and Pregnancy PDF Print E-mail
Wednesday, 21 September 2011 00:14
taken from http://www.flickr.com/photos/lobinhoot/3556091163/ via creative commonsIn an ideal world, men and women would be able to start their families with no difficulties or problems.  However, there are many issues that can complicate matters and Scleroderma and Pregnancy is one of those issues.

It is very important to consult your medical team if you are contemplating a Scleroderma pregnancy, since medications may need to be adjusted beforehand, and specific risk issues can be addressed.

Many systemic scleroderma patients are able to successfully bear children, however it is always considered a "high risk" pregnancy and extra monitoring and precautions are necessary, both before and during pregnancy.

Common sense must prevail, of course. Patients with rapid onset or severe internal organ involvement may need to postpone pregnancy until the symptoms abate or toxic treatments are completed. Depending on the situation, a few people may still be advised to forego pregnancy plans altogether, or to select another route to parenthood (such as adoption or surrogate parenthood).

This information on pregnancy applies only to systemic sclerosis (scleroderma) — such as diffuse, limited, CREST, and overlap — and not to localized forms, such as linear or morphea.

Source: Jane (2011), "Scleroderma And Pregnancy"; Let's Talk Pregnancy. View the full article online here.

 
More articles :

» Juvenile Scleroderma Progression Similar To Adult Onset

The pattern and course of disease in patients who develop systemic sclerosis in childhood or adolescence is similar to that in patients who develop the disease as adults, data from Europe has shown.There were 60 patients among 5,000 included in the...

» Predictors Of Interstitial Lung Disease In Early Systemic Sclerosis

Introduction: The objective of the present study was to examine the association of baseline demographic andclinical characteristics with sequentially obtained measurements of forced vital capacity (FVC), expressed as apercentage of the predicted...

» Finger Ulcers Still a Problem in Scleroderma

A significant number of patients with systemic sclerosis develop , greatly increasing their disease burden and the likelihood of complications, researchers reported here.For instance, 29.8% of patients with one or more digital ulcers developed...

» Unite Against Scleroderma

On May 1st 2011, the would be holding its first annual "Unite Against Scleroderma" Walk around the Queen's Park Savannah, Port Of Spain. It is our aim to help raise awareness of this rare autoimmune disease and the funding needed to aid those who...

» Systemic Sclerosis: A Bird’s Eye Review of Recent Literature

Pathogenesis and new therapeutical targetsTranscription factor Fos-related antigen-2 induces progressive peripheral vasculopathy in mice closely resembling human systemic sclerosis: In this study the authors investigated the potential pathogenetic...

» ArGentis Seeks More Funding After Obtaining Patent for ARG201 Therapy

ArGentis Pharmaceuticals LLC has received a patent for its scleroderma therapy while finalizing plans for a Phase IIb trial for the treatment known as ARG201.The patent comes nearly two years after it was developed by University of Tennessee Health...